US Stocks
/
Aurinia Pharmaceuticals Inc Share Price
Aurinia Pharmaceuticals Inc Share Price

Aurinia Pharmaceuticals Inc Share Price

NASDAQ: AUPH | Mid Cap
$16.15
+$0.13 (0.81%) Last updated on 09 Oct, 2026 | 00:26 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Aurinia Pharmaceuticals Inc Stock Performance

Open
$15.88
Prev. Close
$16.02
Circuit Range
N/A
Day Range
$15.81 - $16.27
Year Range
$10.99 - $19.25
Volume
25,228
Average Traded
$16.02

Aurinia Pharmaceuticals Inc Share Price Today

As of 9 October 2026, Aurinia Pharmaceuticals Inc's share price is $16.15. The stock opened at $15.88, compared to its previous close of $16.02. During today's trading session, Aurinia Pharmaceuticals Inc's share price traded between $15.81 and $16.27, with an average price of $16.04. Over the past 52 weeks, the stock has recorded a high of $19.25 and a low of $10.99. In terms of performance, Aurinia Pharmaceuticals Inc's share price has risen by 5.01% over the last six months and is up 22.53% on a year-on-year basis.

Aurinia Pharmaceuticals Inc Share Price Chart

$15.81$16.27
L
Show Current Price
H

Aurinia Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Market Cap
$2.17B
PE Ratio (TTM)
6.78
Dividend Yield
0.00%
EPS (TTM)
$2.36
Revenue (TTM)
$283.06B
Return On Equity (TTM)
51.09%
Profit Margin
101.46%
Debt to Equity
0.10
Quarterly Earnings Growth YoY
18.57%

Aurinia Pharmaceuticals Inc Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$73.47$77.11$77.71$83.22
Net Profit$31.55$210.79$34.36$37.41
Net Profit Margin42.94%273.36%44.22%44.95%
Income ChangeN/A568.11%-83.70%8.88%

Aurinia Pharmaceuticals Inc Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$134.03$175.51$235.13$283.06
Net Profit-$108.18-$78.02$5.75$287.20
Net Profit Margin-80.71%-44.45%2.45%101.46%
Income ChangeN/A27.88%107.37%4894.78%

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Aurinia Pharmaceuticals Inc Historical Returns

MonthOpenCloseChange %
Oct 2026
$16.12
$16.16
-0.37%
Sep 2026
$16.18
$16.23
-1.43%
Aug 2026
$14.76
$16.46
+10.77%
Jul 2026
$17.05
$14.86
-12.43%
Jun 2026
$15.38
$16.97
+10.73%
May 2026
$15.29
$15.32
-0.36%
Apr 2026
$15.16
$15.38
+3.64%
Mar 2026
$14.38
$14.84
+4.65%
Feb 2026
$14.63
$14.18
-2.48%
Jan 2026
$15.77
$14.54
-8.73%
Dec 2025
$16.09
$15.93
-1.23%
Nov 2025
$13.26
$16.13
+22.37%

AUPH Share Price FAQs

What is Aurinia Pharmaceuticals Inc share price today?

chevron-up
Aurinia Pharmaceuticals Inc share price today is $16.15 as on October 9, 2026 at 12:26 am IST.

What is the 52 week high and 52 week low of Aurinia Pharmaceuticals Inc stock?

chevron-up
The 52 week high of Aurinia Pharmaceuticals Inc stock is $19.25, while the 52 week low is $10.99 as of 9 Oct '26.

What is AUPH's market capitalisation today?

chevron-up
AUPH market capitalisation is $2.17B as of October 9, 2026, at 12:27 am IST.

What is AUPH's net income for the last quarter?

chevron-up
AUPH's net income for the last quarter is 37.41B USD.

What is the 5 year returns of AUPH?

chevron-up
The 5 year returns of AUPH is -51.16% as on 9 Oct '26.

What is the high & low stock price of AUPH today?

chevron-up
AUPH stock price hit a high of $16.27 and low of $15.81 as of 9 Oct '26.

Can I buy AUPH shares in India?

chevron-up
Yes. You can buy AUPH in India by opening an international trading account.